Fetal medicine · Anomaly scan findings
Soft markers on the anomaly scan — what they mean and what they do not
A “soft marker” on the anomaly scan is a finding that is not itself an abnormality but that is statistically associated with an increased chance of fetal aneuploidy or, in some cases, structural anomaly. The mention of a soft marker on a scan report can be deeply worrying. This page explains what each commonly reported soft marker actually means, how it is interpreted in the context of the rest of the pregnancy, and when further evaluation is and is not warranted.
What a soft marker is, and is not
A soft marker is a sonographic finding without structural significance in itself — for example, a small bright spot in the heart muscle (intracardiac echogenic focus) or a slightly dilated kidney pelvis. The marker is reported because it has been statistically associated with chromosomal abnormality in some populations. The marker itself is not the abnormality. A baby with an isolated soft marker is overwhelmingly likely to be born healthy.
The likelihood-ratio framework
Modern interpretation of soft markers uses likelihood ratios. The risk is calculated as:
Baseline risk (from age, NIPT, or combined first-trimester screening) × likelihood ratio for each finding = adjusted risk.
This framework matters because isolated soft markers in a low-risk pregnancy (for example a low-risk NIPT or normal first-trimester screen) often do not raise risk meaningfully. In contrast, two or more soft markers in a pregnancy without prior screening increases the calculation more significantly.
Common soft markers and their meaning
- Intracardiac echogenic focus (ICEF or “golf ball”) — a tiny bright spot in the heart, common, usually isolated, usually a normal variant. Isolated ICEF in a low-risk pregnancy typically requires no further action.
- Echogenic bowel — bowel appearing brighter than bone. Associated with aneuploidy, cystic fibrosis, intrauterine infection, swallowed intrauterine blood, or normal variant. Warrants targeted evaluation including cystic fibrosis carrier status of both parents, CMV/toxoplasma serology, and review of growth and Dopplers.
- Choroid plexus cyst (CPC) — small cysts in the choroid plexus of the lateral ventricles. Common, almost always normal, with no further work-up needed in low-risk pregnancies. Associated with trisomy 18 only when other anomalies are present.
- Mild renal pelvis dilatation — pelvis 4–7 mm in second trimester. Associated weakly with aneuploidy and more relevantly with postnatal urinary tract follow-up. Re-assessed in third trimester.
- Short femur — femur length below expected. Associated with constitutional variation, growth restriction, skeletal dysplasia (rare), and aneuploidy. Re-assessed in context of growth percentile and parental height.
- Single umbilical artery — one umbilical artery instead of two. Associated with aneuploidy and renal anomalies. Detailed cardiac and renal review and growth surveillance follow.
- Absent or hypoplastic nasal bone — second-trimester finding that increases trisomy 21 likelihood. Warrants integrated review with other markers and screening results.
- Increased nuchal fold (≥6 mm at 18–22 weeks) — the strongest of the soft markers. Often prompts the offer of invasive testing.
How findings are integrated
The right interpretation requires putting the marker(s) into the full pregnancy context: age, NIPT or first-trimester screen result, family history, other anomaly-scan findings, growth, and Dopplers. A finding that would be reassuringly isolated in one pregnancy may warrant further work-up in another. The interpretation is therefore individualised.
When further evaluation is offered
- Two or more soft markers in a single pregnancy
- A soft marker with associated structural anomaly
- A soft marker in a pregnancy without prior screening (NIPT or combined first-trimester)
- An increased nuchal fold
- Echogenic bowel
- Family history relevant to the finding
- Parental anxiety where the couple wants definitive information
Further evaluation typically means detailed second-look scanning, NIPT (if not done), or invasive testing.
What this clinic does not do
- We do not over-investigate isolated low-significance soft markers in low-risk pregnancies
- We do not push invasive testing without a clear indication and the couple’s informed choice
- We do not deliver soft-marker findings without a structured explanation of what they mean
- We do not leave the couple to interpret findings alone
The conversation with the couple
Soft markers are explained in plain language, with the actual numerical adjustment to risk where possible. The couple is told the most likely outcome (a healthy baby) alongside the alternatives. Time is given for questions. Where further testing is offered, it is offered as an option, not a mandate.
When to seek a specialist opinion
- A soft-marker finding mentioned in a scan report without a clear explanation
- More than one soft marker in the same pregnancy
- Echogenic bowel or increased nuchal fold
- A soft marker alongside an anatomical finding
- Any soft marker causing significant parental anxiety
Guidelines we follow on this topic
- ISUOG Practice Guideline on Mid-Trimester Anatomy Survey
- SMFM Consult Series on Soft Markers
- RCOG/RCR good practice on second-trimester ultrasound
- Genetic Sonogram literature consensus
Related reading
Dr. Priyadatt Patel
Senior Gynecologist · Advanced Laparoscopic Surgeon · IVF and Endometriosis Programme Lead
MS OBGyn · Pregnancy Care · Advanced Gynaecological Ultrasound · Fertility Preservation
ESHRE / ESGE / AAGL / ASRM guideline-aligned practice. 3D Karl Storz precision technique. Fertility-preservation-first philosophy. Evidence-based decisions, honest counselling, long-term outcomes orientation.
Science City Road, Ahmedabad 380060
Mon–Sat 11:00–20:00 · +91 97234 31544
Naranpura, Ahmedabad
Mon–Sat 08:30–10:30 · +91 70460 02566